Organ transplant recipients remain vulnerable to COVID-19 even after second vaccine dose

EurekAlert! | Dec 12, 2021 at 1:00 AM
  • In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 — the virus that causes COVID 19 — confers some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures.
  • This is a follow-up study to an earlier one published in March in JAMA.
  • In the most recent study, the researchers found that only 98 of the 658 study participants — 15% — had detectable antibodies to SARS-CoV-2 at 21 days after the first vaccine dose.